Rosanna Squitti Selected Research

Copper

12/2023	Serum copper status of patients with colorectal cancer: A systematic review and meta-analysis.
3/2023	Non-Ceruloplasmin Copper Identifies a Subtype of Alzheimer's Disease (CuAD): Characterization of the Cognitive Profile and Case of a CuAD Patient Carrying an RGS7 Stop-Loss Variant.
5/2022	Evaluation of zinc, copper, and Cu:Zn ratio in serum, and their implications in the course of COVID-19.
3/2022	Regulatory miRNAs in Cardiovascular and Alzheimer's Disease: A Focus on Copper.
1/2022	Copper in tumors and the use of copper-based compounds in cancer treatment.
10/2021	Microglia and Astrocytes in Alzheimer's Disease in the Context of the Aberrant Copper Homeostasis Hypothesis.
1/2021	Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants.
1/2021	Non-Ceruloplasmin Copper as a Stratification Biomarker of Alzheimer's Disease Patients: How to Measure and Use It.
1/2021	Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
1/2021	Molecular mechanisms underlying copper function and toxicity in neurons and their possible therapeutic exploitation for Alzheimer's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosanna Squitti Research Topics

Disease

71	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 08/2002
17	Cognitive Dysfunction 01/2021 - 05/2004
12	Dementia (Dementias) 01/2024 - 12/2003
10	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 10/2009
9	Hepatolenticular Degeneration (Wilson's Disease) 01/2021 - 01/2011
4	Stroke (Strokes) 01/2018 - 02/2009
4	Atrophy 01/2017 - 12/2010
3	COVID-19 05/2022 - 01/2021
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 01/2018
3	Inflammation (Inflammations) 07/2020 - 01/2012
3	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2013 - 05/2004
2	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 12/2023
2	Frontotemporal Dementia (Semantic Dementia) 01/2024 - 01/2022
2	Mpox (monkeypox) 01/2023 - 01/2023
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 11/2010
2	Retinal Diseases 01/2021 - 01/2019
2	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 01/2019
2	Glucose Intolerance 07/2020 - 01/2019
2	Schizophrenia (Dementia Praecox) 07/2020 - 12/2006
2	Hepatic Encephalopathy 12/2015 - 10/2014
2	Liver Diseases (Liver Disease) 08/2012 - 10/2009
2	Amyloid Plaque 01/2012 - 11/2009
1	Carcinogenesis 12/2023
1	Pathologic Processes 03/2023
1	Infections 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2022
1	Neoplasms (Cancer) 01/2022
1	Amyloidosis 01/2022
1	Neuroinflammatory Diseases 01/2021
1	Blindness (Hysterical Blindness) 01/2021
1	Pain (Aches) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2020
1	Epilepsy (Aura) 07/2020
1	Autistic Disorder (Autism) 07/2020
1	Neurodevelopmental Disorders 07/2020
1	Chronic Disease (Chronic Diseases) 12/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2019
1	Prediabetic State (Prediabetes) 01/2019

Drug/Important Bio-Agent (IBA)

65	CopperIBA 12/2023 - 08/2002
28	Ceruloplasmin (Ferroxidase)IBA 03/2023 - 02/2007
14	IronIBA 11/2023 - 02/2009
9	ZincIBA 05/2022 - 08/2002
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
8	AntioxidantsIBA 08/2021 - 12/2006
8	Transferrin (beta 2 Transferrin)IBA 01/2020 - 02/2009
7	MetalsIBA 01/2018 - 10/2009
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2008
5	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2013
5	Ferritins (Ferritin)IBA 07/2020 - 04/2013
4	PeroxidesIBA 01/2018 - 05/2004
3	ApolipoproteinsIBA 02/2013 - 02/2006
2	SeleniumIBA 03/2024 - 07/2020
2	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023 - 01/2023
2	tau Proteins (tau Protein)IBA 01/2021 - 01/2017
2	Trace Elements (Biometals)IBA 07/2020 - 02/2013
2	ManganeseIBA 07/2020 - 10/2009
2	DianisidineIBA 08/2017 - 10/2014
2	Apolipoprotein E4IBA 01/2017 - 04/2014
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 06/2013 - 01/2012
2	Apolipoproteins E (ApoE)IBA 02/2013 - 02/2013
2	Amyloid beta-PeptidesIBA 01/2012 - 11/2009
2	Superoxide DismutaseIBA 12/2006 - 08/2002
2	Presenilin-2IBA 04/2005 - 12/2003
1	Protein AggregatesIBA 01/2024
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 10/2023
1	GTP-Binding Proteins (G-Protein)IBA 03/2023
1	Viral DNAIBA 01/2023
1	Hemostatics (Antihemorrhagics)IBA 05/2022
1	MicroRNAs (MicroRNA)IBA 03/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	Free RadicalsIBA 01/2022
1	RadiopharmaceuticalsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 08/2021
1	MicronutrientsIBA 08/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	Prion ProteinsIBA 01/2021
1	CholesterolIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	FlavonoidsIBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	Fenofibrate (CiL)FDA LinkGeneric 01/2021
1	QuercetinIBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2021
1	remdesivirIBA 01/2021
1	SynucleinsIBA 01/2021
1	Lopinavir FDA Link 01/2021
1	CatecholaminesIBA 07/2020
1	Methylphenidate (Ritalin)FDA LinkGeneric 07/2020
1	Antipsychotic Agents (Antipsychotics)IBA 07/2020
1	CobaltIBA 07/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	Genetic Markers (Genetic Marker)IBA 01/2020
1	Insulin (Novolin)FDA Link 12/2019

Therapy/Procedure

5	Therapeutics 01/2022 - 11/2009
1	Drug Therapy (Chemotherapy) 01/2022